PREMIQUE

This brand name is authorized in Ireland, UK.

Active ingredients

The drug PREMIQUE contains a combination of these active pharmaceutical ingredients (APIs):

1	Estrogens, conjugated UNII IU5QR144QX - ESTROGENS, CONJUGATED
	The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estrogens, conjugated
2	Medroxyprogesterone UNII HSU1C9YRES - MEDROXYPROGESTERONE
	Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.
	Read more about Medroxyprogesterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PREMIQUE Modified release tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03FA12	Medroxyprogesterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	73404